Orchard Therapeutics (Orchard Therapeutics) Days Inventory : 354.93 (As of Sep. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Orchard Therapeutics Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Orchard Therapeutics's Average Total Inventories for the three months ended in Sep. 2023 was $6.79 Mil. Orchard Therapeutics's Cost of Goods Sold for the three months ended in Sep. 2023 was $1.75 Mil. Hence, Orchard Therapeutics's Days Inventory for the three months ended in Sep. 2023 was 354.93.

The historical rank and industry rank for Orchard Therapeutics's Days Inventory or its related term are showing as below:

ORTX' s Days Inventory Range Over the Past 10 Years
Min: 145.98 Med: 283.23 Max: 2164.97
Current: 269.54

During the past 7 years, Orchard Therapeutics's highest Days Inventory was 2164.97. The lowest was 145.98. And the median was 283.23.

ORTX's Days Inventory is not ranked
in the Biotechnology industry.
Industry Median: 191.14 vs ORTX: 269.54

Orchard Therapeutics's Days Inventory increased from Sep. 2022 (117.96) to Sep. 2023 (354.93). It might indicate that Orchard Therapeutics's sales slowed down.

Warning Sign:

If a company builds up inventory, it may mean it is having difficulties selling its goods.

Inventory Turnover measures how fast the company turns over its inventory within a year. Orchard Therapeutics's Inventory Turnover for the three months ended in Sep. 2023 was 0.26.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Orchard Therapeutics's Inventory-to-Revenue for the three months ended in Sep. 2023 was 1.08.

Orchard Therapeutics Days Inventory Historical Data

The historical data trend for Orchard Therapeutics's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orchard Therapeutics Days Inventory Chart

Orchard Therapeutics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Days Inventory

Get a 7-Day Free Trial

283.23

2,164.97

145.98

Orchard Therapeutics Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Days Inventory	Get a 7-Day Free Trial															117.96	107.53	1,113.27	260.37	354.93

Competitive Comparison of Orchard Therapeutics's Days Inventory

For the Biotechnology subindustry, Orchard Therapeutics's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Orchard Therapeutics's Days Inventory Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Orchard Therapeutics's Days Inventory distribution charts can be found below:

* The bar in red indicates where Orchard Therapeutics's Days Inventory falls into.

Orchard Therapeutics Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Orchard Therapeutics's Days Inventory for the fiscal year that ended in Dec. 2022 is calculated as

	Days Inventory (A: Dec. 2022 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Dec. 2021 )	+	Total Inventories (A: Dec. 2022 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2022 )	*	Days in Period
=	( (2.016	+	3.4)	/	2 )	/	6.771	*	365
=	2.708					/	6.771	*	365
=	145.98

Orchard Therapeutics's Days Inventory for the quarter that ended in Sep. 2023 is calculated as:

	Days Inventory (Q: Sep. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Jun. 2023 )	+	Total Inventories (Q: Sep. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Sep. 2023 )	*	Days in Period
=	( (6.937	+	6.638)	/	2 )	/	1.745	*	365 / 4
=	6.7875					/	1.745	*	365 / 4
=	354.93

Orchard Therapeutics (NAS:ORTX) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Orchard Therapeutics's Inventory Turnover for the three months ended in Sep. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	1.745	/	6.7875
	=	0.26

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Orchard Therapeutics's Inventory to Revenue for the three months ended in Sep. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	6.7875	/	6.302
	=	1.08

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Orchard Therapeutics Days Inventory Related Terms

Thank you for viewing the detailed overview of Orchard Therapeutics's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Orchard Therapeutics (Orchard Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Orchard Therapeutics PLC (NAS:ORTX) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

OT10:Germany

Address

245 Hammersmith Road, London, GBR, W6 8PW

Website

https://www.orchard-tx.com

Orchard Therapeutics PLC is a United Kingdom-based commercial-stage, a fully-integrated biopharmaceutical company. The company is engaged in transforming the lives of patients with serious and life-threatening rare diseases through autologous ex vivo gene therapies. It operates in three geographic regions: the United Kingdom, European Union, and the United States. Orchard Rx is focusing on its autologous ex vivo gene therapy approach on three therapeutic rare disease franchise areas: primary immune deficiencies, neurometabolic disorders, and hemoglobinopathies. Its portfolio includes Strimvelis, used for the treatment of ADA-SCID five lentiviral product candidates.

Executives

Bobby Gaspar	director, officer: See Remarks	ORCHARD THERAPEUTICS PLC, 108 CANNON STREET, LONDON X0 EC4N 6EU
Fmr Llc	10 percent owner, other: See Remark 1	245 SUMMER STREET, BOSTON MA 02210
Ra Capital Healthcare Fund Lp	10 percent owner	200 BERKELEY STREET, 18TH FLOOR, BOSTON MA 02116
Ra Capital Management, L.p.	10 percent owner	200 BERKELEY STREET, 18TH FLOOR, BOSTON MA 02116
Peter Kolchinsky	10 percent owner	200 BERKELEY STREET, 18TH FLOOR, BOSTON MA 02116
Rajeev M. Shah	10 percent owner	200 BERKELEY STREET, 18TH FLOOR, BOSTON MA 02116
Steven Altschuler	director	MEAD JOHNSON NUTRITION COMPANY, 2701 PATRIOT BLVD, GLENVIEW IL 60026
Jon Ellis	director	ORCHARD THERAPEUTICS PLC, 108 CANNON STREET, LONDON X0 EC4N 6EU
Plc Glaxosmithkline	director, 10 percent owner	980 GREAT WEST ROAD, BRENTFORD MIDDLESEX X0 TW8 9GS
Marc Dunoyer	director	ORCHARD THERAPEUTICS PLC, 108 CANNON STREET, LONDON X0 EC4N 6EU
John T Curnutte	director	PORTOLA PHARMACEUTICALS, INC., 270 EAST GRAND AVENUE, SOUTH SAN FRANCISCO CA 94080
Rowland Charles A Jr	director	3338 LANCASHIRE RD, FURLONG PA 18925
Mark Rothera	director, officer: See Remarks	C/O AEGERION PHARMACEUTICALS, INC., 101 MAIN STREET, SUITE 1850, CAMBRIDGE MA 02142
James A Geraghty	director	C/O IDERA PHARMACEUTICALS, INC., 167 SIDNEY STREET, CAMBRIDGE MA 02139
Alicia Secor	director	33 HAYDEN AVE., LEXINGTON MA 02421